The cancelled contract had funded Moderna’s early-stage development of an H5 avian flu vaccine, which the company says showed “positive interim” results in a study involving 300 healthy adults.
The move allows the company to reorganise under legal protection as it battles to secure emergency funding and stave off collapse.
CPC’s growth has been underpinned by its vertically integrated operations that span the entire poultry production cycle, from breeder farms and hatcheries to broiler growing and processing facilities.
The outbreak, reported on April 16, marks Brazil’s first instance of avian influenza in a commercial poultry setting.
The distributed birds are suitable for both meat and egg production, and are expected to help address nutritional deficiencies and income instability in underserved areas.
The company, owned by the government’s Public Investment Corporation (PIC), is reported to be in deep financial distress, which has led to a breakdown in basic animal care.
This partnership is poised to empower businesses across the feed value chain with the technical, regulatory, and market intelligence needed to bring new nutritional technologies to market.
With demand for poultry products steadily rising in China, the registration provides Jorenku with a firm foothold in a market hungry for solutions that enhance animal health and production efficiency.
The discussions focused on establishing a state-of-the-art facility in Egypt with a production capacity of up to 200 million vaccine doses annually.
With a growing footprint in both Gulf and non-Gulf countries, the company aims to deliver faster service and customised technical support.